Brexit and the Healthcare Industry - Implications for Pharma, Q1 2018

Market: Pharmaceuticals and Healthcare

Global, 40 pages report, published by GlobalData

Report ThumbnailMay-2018
Brexit and the Healthcare Industry - Implications for Pharma, Q1 2018

Summary

It has been almost two years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Negotiations are ongoing to determine the UK’s post-Brexit relationship with the EU.

This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This st

Read More
  • Table of Contents
  • 1 Study Design
  • 1.1 Background, Objectives, and Design
  • 1.2 Respondent Mix - Geography
  • 1.3 Respondent Mix - Seniority Level
  • 1.4 Respondent Mix - Headquarters Location
  • 2 Executive Summary
  • 2.1 Key Findings
  • 3 Overview of UK Pharma Industry
  • 3.1 The UK Pharma Industry - A Key Driver of the UK Economy
  • 3.2 The UK as an Attractive Location for Clinical Trials
  • 4 Brexit Timeline
  • 5 Factors to Impact Healthcare
  • 5.1 Key Factors to Impact the Post-Brexit UK Healthcare Industry
  • 5.2 Key Factors
Read More

Please select a license type

Share

Related Products

GlobalDataBrexit and the Healthcare Industry - Implications for Pharma, Q1 2018Product ThumbnailBrexit and the Healthcare Industry - Implications for Pharma, Q1 2018, Industry ReportProduct #: 1179501
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved